PTH(1-84)
Showing 1 - 25 of >10,000
Coronary Calcification, Endstage Renal Disease, Parathyroid Hormone Trial in Charlotte (Doxercalciferol administration,
Withdrawn
- Coronary Calcification
- +2 more
- Doxercalciferol administration
- Doxercalciferol administered by 1-84-7-84
-
Charlotte, North CarolinaDavita East Charlotte Dialysis Unit
Dec 20, 2020
Hypoparathyroidism Trial in Worldwide (25mcg rhPTH(1-84), 50mcg rhPTH(1-84), 100mcg rhPTH(1-84))
Completed
- Hypoparathyroidism
- 25mcg rhPTH(1-84)
- +2 more
-
North Hollywood, California
- +14 more
May 20, 2021
Secondary Hyperparathyroidism Trial (PLS240, Placebo, Open-Label Extension PLS240)
Not yet recruiting
- Secondary Hyperparathyroidism
- PLS240
- +2 more
- (no location specified)
Apr 17, 2023
Osteoporotic Fractures Trial in New York (Teriparatide Prefilled Syringe, Placebo)
Completed
- Osteoporotic Fractures
- Teriparatide Prefilled Syringe
- Placebo
-
New York, New YorkHospital for Special Surgery
Jul 26, 2022
Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)
Not yet recruiting
- Advanced Solid Tumors
- LCB84
- Anti-PD-1 monoclonal antibody
-
Los Angeles, California
- +6 more
Jul 4, 2023
Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo for TransCon PTH)
Active, not recruiting
- Hypoparathyroidism
- +2 more
- TransCon PTH
- Placebo for TransCon PTH
-
Chicago, Illinois
- +14 more
Mar 2, 2022
Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo)
Active, not recruiting
- Hypoparathyroidism
- +2 more
- TransCon PTH
- Placebo
-
San Francisco, California
- +20 more
Aug 5, 2022
Chronic Hypoparathyroidism, Hypoparathyroidism Trial in New York (rhPTH(1-84))
Completed
- Chronic Hypoparathyroidism
- Hypoparathyroidism
-
New York, New YorkColumbia University Medical Center
Jul 27, 2021
Stress Fracture Trial in Norwich (Teriparatide)
Completed
- Stress Fracture
-
Norwich, Norfolk, United KingdomNorfolk and Norwich University Hospitals Foundation Trust
Aug 5, 2021
Hypoparathyroidism Trial in Worldwide (rhPTH(1-84), Placebo)
Completed
- Hypoparathyroidism
- rhPTH(1-84)
- Placebo
-
Chicago, Illinois
- +39 more
May 23, 2022
Male Osteoporosis Trial in San Francisco (Teriparatide or human parathyroid hormone (PTH) 1-34, Cinacalcet, tablet)
Recruiting
- Male Osteoporosis
- Teriparatide or human parathyroid hormone (PTH) 1-34
- +4 more
-
San Francisco, CaliforniaSan Francisco VA Medical Center, San Francisco, CA
Dec 8, 2021
Hypoparathyroidism Trial in Jerusalem (EB612 (EBP05), NATPARA/NATPAR)
Completed
- Hypoparathyroidism
- EB612 (EBP05)
- NATPARA/NATPAR
-
Jerusalem, IsraelClinical Research Center Hadassah Ein Kerem Medical Center
Mar 22, 2019
Ankle Fractures Trial in Istanbul (WALANT in Ankle Fractures (Wide-Awake Local) Anesthesia No Tourniquet) and Applied Under
Recruiting
- Ankle Fractures
- WALANT in Ankle Fractures (Wide-Awake Local) Anesthesia No Tourniquet) and Applied Under Spinal Anesthesia Comparison of Clinical Results of Surgical Treatment;ANT Procedure comparation
- Applied Under Spinal Anesthesia of Clinical Results of Surgical Treatment
-
Istanbul, Çapa / Fatih, TurkeyIstanbul University, Istanbul Faculty of Medicine, Department Or
Oct 8, 2023
Progressive Supranuclear Palsy Trial in Seongnam-si, Seoul (GV1001 Placebo, GV1001 0.56mg, GV1001 1.12mg)
Not yet recruiting
- Progressive Supranuclear Palsy
- GV1001 Placebo
- +2 more
-
Seongnam-si, Korea, Republic of
- +4 more
Apr 19, 2023
Pneumoccocal Immunisation Trial in United States (Pneumococcal Conjugate Vaccine - formulation 1, Pneumococcal Conjugate Vaccine
Completed
- Pneumoccocal Immunisation
- Pneumococcal Conjugate Vaccine - formulation 1
- +4 more
-
Anaheim, California
- +16 more
Aug 1, 2022
Influenza, Immunization, Older Adults Trial in Baltimore (Influenza)
Recruiting
- Influenza
- +3 more
- Influenza
-
Baltimore, MarylandJohns Hopkins University; JHAAC 5501 Hopkins Bayview Circle, 1B8
Mar 14, 2022
Moderate to Severe Alzheimer's Disease Trial (GV1001 Placebo, GV1001 0.56mg, GV1001 1.12mg)
Not yet recruiting
- Moderate to Severe Alzheimer's Disease
- GV1001 Placebo
- +2 more
- (no location specified)
Mar 28, 2022
Healthy Participants Trial in Toronto (IONIS FXI-LRx, Placebo)
Completed
- Healthy Participants
- IONIS FXI-LRx
- Placebo
-
Toronto, Ontario, CanadaBioPharma Services Inc.
Jan 13, 2022
Venezuelan Equine Encephalomyelitis Trial in Fort Deterick (0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1)
Not yet recruiting
- Venezuelan Equine Encephalomyelitis
- 0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1
-
Fort Deterick, MarylandSpecial Immunizations Program/USAMRIID
Feb 10, 2021